authors
- Bjarnason, Georg A
- Basappa, Naveen S
- Knox, Jennifer J
- Kollmannsberger, Christian K
- Reaume, M Neil Neil
- Lalewski, Pawel
- Macfarlane, Robyn Jane
- MacKenzie, Mary J
- Hotte, Sebastien
- Heng, Daniel Vick Chin
- Soulieres, Denis
- Miller, Jessie
A phase II multicenter study of the efficacy and safety of sunitinib given on an individualized schedule as first-line therapy for metastatic renal cell cancer.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- May 20, 2013
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal